Silodosin Side Effects on Sexual Health and Blood Pressure

Silodosin’s most common side effect is abnormal ejaculation, reported by roughly one in four men in clinical trials and far more frequently than with other drugs in its class. Beyond that signature issue, silodosin is generally well tolerated, with unusually low rates of blood-pressure-related problems like dizziness and orthostatic hypotension. That tradeoff shapes most conversations between patients and prescribers, but there are several other side effects, drug interactions, and edge cases worth understanding before you start or continue the medication.

Why Ejaculatory Dysfunction Is So Common

Silodosin is prescribed for lower urinary tract symptoms caused by an enlarged prostate. It works by blocking a specific type of receptor in the prostate and bladder neck, relaxing those muscles so urine flows more easily. Its selectivity for that particular receptor subtype is roughly 580 times greater than for the receptor subtype found in blood vessels, which explains both its effectiveness in the urinary tract and its low impact on blood pressure.¹ The same receptor it blocks so effectively, though, is also concentrated in the seminal vesicles and the muscles involved in ejaculation.

The result is what urologists loosely call “abnormal ejaculation,” which in practice means a few different things happening at once. Ultrasound studies have shown that the problem involves retrograde flow of seminal fluid back into the bladder, weaker contractions of the seminal vesicles, and reduced rhythmic contractions of the pelvic floor muscles.² So it is not purely retrograde ejaculation in the textbook sense. In many men the ejaculate volume drops dramatically or disappears entirely, while in others there is a mixture of reduced volume and some backward flow.

In controlled clinical trials, the rate of this side effect typically exceeds 22%.³ A study that specifically examined sexually active men on silodosin found that 90% experienced impaired ejaculation, alongside a measurable enlargement of their seminal vesicles during treatment.⁴ That 90% figure is higher than the 22% from broader trials partly because the broader studies include men who are not sexually active and would not notice or report ejaculatory changes. Among men who are regularly having sex, the real-world rate is considerably higher than the headline trial number suggests.

Does It Affect Sexual Function Beyond Ejaculation

The distinction matters: silodosin impairs ejaculation, but the research suggests it largely spares other aspects of sexual function. In the same study that found 90% of sexually active men had ejaculatory changes, orgasmic function, sexual desire, satisfaction with intercourse, and overall satisfaction scores did not change significantly. Erectile function scores dipped slightly but the drop was modest.⁵ Men can still reach orgasm; the physical sensation is typically preserved even when little or no fluid comes out. For some men this is a minor nuisance, while for others, particularly those trying to conceive or those who find the change psychologically distressing, it is a dealbreaker.

A Turkish study found that about half of patients experienced abnormal ejaculation, and among those who did, roughly 42% wanted to stop the medication because of it. But patients who were happy with how well silodosin relieved their urinary symptoms tended to accept the ejaculatory side effect and wanted to keep taking the drug.⁶ In other words, the tradeoff is very individual. If your urinary symptoms improve enough, you may find the ejaculatory change tolerable; if the urinary benefit is marginal, the ejaculatory issue feels like an unacceptable cost.

Blood Pressure and Dizziness

One of silodosin’s genuine advantages over older alpha-blockers is its minimal effect on blood pressure. Older drugs in this class, like doxazosin and terazosin, block receptors in blood vessels more broadly and can cause noticeable drops in blood pressure when you stand up. Silodosin’s extreme selectivity sidesteps most of that problem. In controlled trials, the incidence of orthostatic hypotension was under 3%.⁷

Head-to-head trials against tamsulosin, which is probably the most widely prescribed drug in this class, illustrate the difference. In one non-inferiority trial, tamsulosin caused a statistically significant drop in systolic blood pressure averaging about 4 mmHg, while silodosin’s change was essentially zero.⁸ In a separate randomized trial for acute urinary retention, dizziness and vertigo were reported by seven patients on tamsulosin versus only two on silodosin, and headaches by four on tamsulosin versus none on silodosin.⁹

That said, dizziness can still happen. A phase I safety study in healthy volunteers noted mild dizziness, headache, and postural hypotension as possible events, even if uncommon.¹⁰ If you already take blood-pressure-lowering medication, the risk of feeling lightheaded when you stand up could be slightly higher, so it is worth mentioning to your prescriber.

How Silodosin Compares to Other Alpha-Blockers Overall

A large network meta-analysis comparing all major alpha-blockers for enlarged prostate confirmed the pattern: silodosin carries a higher total count of adverse events than the competition, driven almost entirely by ejaculatory dysfunction. Among the alpha-blockers analyzed, silodosin had 190 adverse events across 739 participants, while tamsulosin had 32 across 966.¹¹ A separate systematic review found that silodosin’s overall adverse event rate was about 25% higher than tamsulosin’s, but again, the dominant driver was retrograde ejaculation, which occurred roughly seven to eight times more often with silodosin than with tamsulosin.¹²

On the flip side, the same meta-analyses consistently show silodosin performs at least as well as tamsulosin for symptom relief, and possibly a bit better for voiding symptoms specifically.¹³ A three-arm trial comparing silodosin, tamsulosin, and alfuzosin found that the proportion of patients developing side effects was lowest in the silodosin group at most time points, once you set aside the ejaculatory issue. Dizziness was the most common complaint across all three drugs. Fatigue showed up with tamsulosin and alfuzosin but not silodosin, while insomnia and syncope (fainting) appeared only in the silodosin group in small numbers.¹⁴ There was no statistically significant difference in total adverse events between the three groups.

A randomized trial conducted in India reported a similar picture: retrograde ejaculation appeared only in the silodosin arm (about 23% of sexually active men), while postural hypotension appeared only in the tamsulosin arm.¹⁵ This tradeoff is one of the most consistent findings in the silodosin literature and often comes down to which side effect you would rather live with.

Digestive Side Effects

A less-discussed side effect is gastrointestinal trouble. A study specifically looking at stool changes in men taking different alpha-blockers found that silodosin was associated with increased digestive symptoms, particularly diarrhea and loose stools.¹⁶ The receptors silodosin targets exist in the gut as well, which likely explains the effect. The researchers recommended that prescribers consider a patient’s baseline digestive health when choosing among alpha-blockers. If you already deal with irritable bowel symptoms or have a tendency toward loose stools, this side effect might be more noticeable or bothersome than average.

Eye Concerns During Cataract Surgery

If you are taking or have ever taken silodosin and need cataract surgery, make sure your ophthalmologist knows. Alpha-blockers are linked to a complication called intraoperative floppy iris syndrome, where the iris becomes unusually floppy and tends to billow or constrict unpredictably during surgery. Among the alpha-blockers, silodosin appears to carry the highest risk.

An observational study comparing cataract surgery outcomes across different alpha-blockers found that floppy iris syndrome occurred in about 37% of silodosin users, compared to about 22% of tamsulosin users, 11% of alfuzosin users, and 3% of controls. After adjusting for other variables, silodosin carried roughly eight times the odds of this complication compared to patients not on any alpha-blocker.¹⁷ The condition does not necessarily mean the surgery goes badly, as experienced cataract surgeons can manage it with special techniques, but being caught off guard by it can lead to complications. Stopping silodosin before surgery does not reliably prevent the issue because the iris changes can persist long after the drug is out of your system. The key is advance warning so the surgeon can plan accordingly.

Combining Silodosin With Erectile Dysfunction Drugs

Many men with enlarged-prostate symptoms also use medications for erectile dysfunction, which raises the question of whether combining silodosin with drugs like sildenafil or tadalafil is safe. Both classes of medication can lower blood pressure to some degree, so there is theoretical concern about additive drops, especially upon standing.

A dedicated pharmacodynamic study tested exactly this. Healthy men took silodosin alongside full therapeutic doses of sildenafil and tadalafil in a controlled setting. The combination produced no clinically meaningful orthostatic blood pressure changes and no orthostatic symptoms. The number of positive orthostatic tests was similar whether men received the erectile dysfunction drug or placebo alongside silodosin.¹⁸ A broader meta-analysis of alpha-blockers combined with PDE5 inhibitors found that while the combination does slightly increase the chance of hemodynamic changes on paper, actual hypotension-related adverse events were no more frequent than with alpha-blocker monotherapy.¹⁹ The reassuring safety picture here is largely because silodosin spares vascular receptors. If you were on an older, less selective alpha-blocker, the combination would require more caution.

Long-Term Tolerability and Persistence

Extension studies lasting up to nine months in Europe showed that about a third of patients experienced some adverse event over that period, with ejaculatory dysfunction being the most common at 9%. Only 1.6% stopped the drug because of it, and dizziness without orthostatic hypotension occurred in under 1%.²⁰ Follow-up studies in the US, Europe, and Asia broadly confirmed that the side-effect profile stays stable over time, without new adverse effects emerging with prolonged use.²¹

A six-year Japanese follow-up study tracked 104 patients who started silodosin. Adverse events were reported in about 14% overall, with ejaculatory dysfunction at roughly 6%. By the six-year mark, 25% were still taking silodosin. Among those who stopped, the most common reason was unsatisfactory symptom relief (about 29%), followed by unknown reasons (26%) and adverse events (about 9%).²² The fact that adverse events ranked third among reasons for discontinuation, behind dissatisfaction with efficacy, tells you something about the drug’s tolerability in practice. Most men who stop do so because the drug is not helping enough, not because of side effects.

Are the Side Effects Reversible

Yes, and this is one of silodosin’s more reassuring features. A study that tracked patients after they stopped taking the drug found that all symptoms of adverse events resolved immediately upon discontinuation.²³ Ejaculatory function returns to baseline once the drug clears your system, which happens within a day or two given silodosin’s short half-life. The seminal vesicle enlargement observed during treatment also normalizes. This reversibility makes it a reasonable drug to trial: if the ejaculatory side effect bothers you more than the urinary relief helps, you can stop and expect a rapid return to your previous baseline.

The one caveat to “fully reversible” involves the eye. As mentioned, iris changes linked to alpha-blockers can persist indefinitely and do not reliably reverse after stopping the drug. If cataract surgery is in your near future, talking to both your urologist and your ophthalmologist before starting silodosin is worthwhile, even though the urinary side effects themselves will reverse if you stop.

Kidney and Liver Considerations

Silodosin is considered safe for men with mild to moderate liver dysfunction at standard therapeutic doses. For kidney impairment, however, dosage adjustment is recommended in men with moderate renal impairment, because the drug’s clearance is reduced and blood levels can build up.²⁴ Men with severe kidney disease are generally not candidates for silodosin. If you have kidney issues, your prescriber will likely either reduce the dose or choose a different alpha-blocker that is not as dependent on renal clearance.

Off-Label Use and Kidney Stones

Silodosin is sometimes prescribed off-label to help pass small kidney stones lodged in the lower ureter. The same receptor-blocking action that relaxes the prostate also relaxes the smooth muscle of the ureter, potentially easing stone passage. A comparative study of silodosin versus tamsulosin for distal ureteral stones found similar rates of stone passage with both drugs, with slightly more retrograde ejaculation in the silodosin group, though the difference was not statistically significant.²⁵ In this context, the course of treatment is usually just a few weeks rather than ongoing, so the ejaculatory side effect is temporary by design. The short-term nature of the prescription makes the side-effect tradeoff easier to accept for most patients.

This off-label use also means women can be prescribed silodosin for ureteral stones. The ejaculatory side effect is obviously irrelevant in that population, and the cardiovascular profile remains favorable, making it a relatively clean short-course prescription for stone passage regardless of sex.